Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemia. - Liu P; Zhang S; Chen BY; Chang B; Jiang Y; Li X; Chen X; Li ZJ; Yang R; Wang X; Xu CH; Liu X; et al. (Science translational medicine, 2026)